A patient with Stage 3b Chronic Kidney Disease (CKD) presents with elevated potassium levels, anemia, and worsening kidney function. Which nursing intervention should be prioritized to address these findings?

C) Monitor the patient for signs of hyperkalemia and prepare to administer sodium polystyrene sulfonate as ordered.

A) Encourage a diet high in potassium-rich foods.

B) Educate the patient on the importance of blood pressure management.

C) Monitor the patient for signs of hyperkalemia and prepare to administer sodium polystyrene sulfonate as ordered.

D) Increase the patient's protein intake to address proteinuria.

A patient with Stage 3b Chronic Kidney Disease presents with elevated serum creatinine, elevated BUN, hyperkalemia, anemia, and proteinuria. Considering these lab findings, which of the following interventions should the nurse prioritize to address the patient's hyperkalemia and prevent further complications?

B) Administer sodium polystyrene sulfonate as prescribed to lower potassium levels

A) Increase dietary potassium intake to balance electrolyte levels

B) Administer sodium polystyrene sulfonate as prescribed to lower potassium levels

C) Encourage increased water intake to dilute potassium concentration in the blood

D) Suggest the patient consume a high-protein diet to manage proteinuria

A patient with chronic kidney disease (CKD) is experiencing increased fatigue, dizziness upon standing, mild peripheral edema, and has a recent blood pressure reading of 98/60 mmHg. Based on this clinical presentation, which of the following interventions should the nurse prioritize to address the patient's current condition?

C) Administer a prescribed diuretic to reduce peripheral edema and monitor the patient’s fluid status closely.

A) Increase the dosage of antihypertensive medication to better control blood pressure.

B) Educate the patient on reducing sodium intake to help with fluid retention and blood pressure control.

C) Administer a prescribed diuretic to reduce peripheral edema and monitor the patient’s fluid status closely.

D) Encourage the patient to increase fluid intake to counteract hypotension symptoms.

A patient with chronic kidney disease (CKD) reports increased fatigue and dizziness when standing, alongside new peripheral edema. His blood pressure reading is 98/60 mmHg, and recent bloodwork shows mild metabolic acidosis. Which nursing intervention is most appropriate to address the patient's symptoms and prevent further complications?

A) Educate the patient on the importance of a low-sodium diet to manage fluid retention.

B) Instruct the patient to increase fluid intake to counteract dizziness and improve blood pressure.

C) Recommend the patient to avoid standing quickly to prevent dizziness from orthostatic hypotension.

D) Suggest the patient take over-the-counter diuretics to reduce peripheral edema.

A patient with chronic kidney disease on a modified antihypertensive regimen and loop diuretic therapy presents with mild hypokalemia and new-onset muscle cramps. Which intervention should the nurse prioritize to address the patient's electrolyte imbalance?

B) Administer prescribed potassium supplements.

A) Increase dietary intake of potassium-rich foods.

B) Administer prescribed potassium supplements.

C) Restrict fluid intake to reduce diuretic effects.

D) Discontinue the loop diuretic immediately.

A patient with chronic kidney disease is being treated with a loop diuretic and presents with new-onset muscle cramps and a potassium level of 3.2 mmol/L. What would be the most appropriate nursing intervention to address the patient's symptoms and electrolyte imbalance?

C) Administer oral potassium supplements as prescribed.

A) Increase the dosage of the loop diuretic to enhance diuretic effect.

B) Encourage the patient to increase dietary intake of potassium-rich foods.

C) Administer oral potassium supplements as prescribed.

D) Restrict the patient's fluid intake to prevent further fluid overload.

A patient with chronic kidney disease on diuretic therapy presents with persistent muscle cramps, tingling sensations in the extremities, and laboratory findings show hypokalemia, mild hypomagnesemia, and stable metabolic acidosis. Which of the following interventions should the nurse prioritize to address the patient's current symptoms and prevent further complications?

A) Administer oral potassium and magnesium supplements as prescribed.

B) Increase fluid intake to enhance diuretic effectiveness.

C) Advise the patient to avoid potassium-rich foods to prevent hyperkalemia.

D) Initiate calcium supplementation immediately to correct potential hypocalcemia.

A patient with chronic kidney disease is experiencing persistent muscle cramps and tingling sensations in the extremities. The laboratory results show hypokalemia, low normal calcium, and slightly low magnesium levels. Which of the following interventions should the nurse prioritize to address the patient's symptoms and prevent further complications?

A) Administer oral potassium supplements and educate the patient on increasing dietary potassium intake.

B) Start intravenous calcium gluconate to promptly correct the low calcium levels.

C) Increase the dosage of diuretics to manage fluid overload more effectively.

D) Advise the patient to restrict magnesium-rich foods to avoid hypermagnesemia.

A patient with chronic kidney disease is experiencing increased fatigue and weakness, with recent labs indicating an elevated serum creatinine level and low magnesium level. The healthcare team has adjusted the treatment plan by reducing the dosage of diuretics and emphasizing dietary adjustments. Which intervention should the nurse prioritize to support the patient's renal function and electrolyte balance?

B) Educate the patient on including magnesium-rich foods in the diet such as nuts and leafy green vegetables.

A) Encourage the patient to increase fluid intake to dilute serum creatinine levels.

B) Educate the patient on including magnesium-rich foods in the diet such as nuts and leafy green vegetables.

C) Suggest the patient limit protein intake to reduce renal workload.

D) Advise the patient to avoid potassium-rich foods to prevent hyperkalemia.

A patient with chronic kidney disease presents with fatigue, weakness, and an increase in serum creatinine levels. The healthcare team adjusts the treatment plan by reducing diuretics and emphasizing electrolyte supplementation. Considering the patient's condition, what is the most appropriate nursing intervention to prevent further renal deterioration?

B) Educate the patient about a low-protein diet to reduce kidney workload.

A) Encourage the patient to increase fluid intake to flush out toxins.

B) Educate the patient about a low-protein diet to reduce kidney workload.

C) Advise the patient to consume high-magnesium foods to correct deficiencies.

D) Recommend increased physical activity to improve overall health.

chronic kidney disease - Nursing Case Study

Pathophysiology

• Primary mechanism: Chronic kidney disease (CKD) often begins with damage to the nephrons, leading to reduced filtration capacity. This damage is frequently caused by conditions like diabetes and hypertension, which result in glomerular sclerosis and tubular atrophy. Over time, the remaining nephrons become overworked, accelerating further damage.

• Secondary mechanism: As nephron function declines, there is an accumulation of waste products and electrolyte imbalances, particularly elevated serum creatinine and urea. The inability to excrete sodium and water effectively leads to fluid retention, contributing to hypertension and edema.

• Key complication: As CKD progresses, decreased erythropoietin production by the failing kidneys leads to anemia, further reducing oxygen delivery to tissues and exacerbating fatigue and cardiovascular stress.

Patient Profile

Demographics:

62-year-old male, retired teacher

History:

• Key past medical history: Hypertension for 15 years, Type 2 Diabetes for 10 years, Stage 3 Chronic Kidney Disease diagnosed 2 years ago

• Current medications: Lisinopril 20 mg daily, Metformin 500 mg twice daily, Atorvastatin 20 mg daily

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increasing fatigue and swelling in legs

• Key symptoms: Fatigue, peripheral edema, nocturia, reduced appetite, mild shortness of breath

• Vital signs: Blood pressure 150/95 mmHg, heart rate 88 bpm, respiratory rate 20 breaths/min, temperature 98.6°F, oxygen saturation 94% on room air

Section 1

New Diagnostic Results:

As the healthcare team continues to monitor the patient, recent lab results reveal significant changes that provide further insight into his current condition. The patient's serum creatinine has risen to 2.6 mg/dL from a previous 2.2 mg/dL, indicating a further decline in kidney function. Blood urea nitrogen (BUN) levels are also elevated at 35 mg/dL. The glomerular filtration rate (GFR) has decreased to 38 mL/min/1.73m², suggesting progression to the upper limit of Stage 3b Chronic Kidney Disease. Additionally, a complete blood count shows a hemoglobin level of 10.2 g/dL, confirming the presence of anemia likely due to decreased erythropoietin production by the kidneys.

Electrolyte imbalances are also apparent, with hyperkalemia noted at a potassium level of 5.8 mmol/L, potentially contributing to the patient's mild shortness of breath and fatigue. The urinalysis results highlight proteinuria and microalbuminuria, further confirming the nephron damage and ongoing kidney stress. These findings necessitate a reassessment of the current treatment regimen, particularly the management of hypertension and diabetes, as well as the introduction of measures to address the anemia and electrolyte imbalances.

The clinical team must now consider potential interventions, such as the adjustment of antihypertensive medications to better control blood pressure, the possible initiation of erythropoiesis-stimulating agents to manage anemia, and dietary modifications to address the electrolyte disturbances. These changes are critical to slowing the progression of CKD, managing symptoms effectively, and improving the patient's overall quality of life. The patient and his family will need education on these adjustments, emphasizing the importance of adherence to the modified treatment plan and regular follow-up appointments to monitor his condition closely.

Section 2

Following the adjustments to the treatment plan, the healthcare team closely monitors the patient for any changes in his condition. Upon the latest assessment, the patient reports experiencing increased fatigue and episodes of dizziness, particularly upon standing, which may indicate orthostatic hypotension. His blood pressure readings show variability, with a recent measurement of 98/60 mmHg, suggesting potential over-adjustment of antihypertensive medications. This highlights the need for fine-tuning the current regimen to maintain optimal blood pressure control without inducing hypotension, which could further compromise renal perfusion.

In addition to the blood pressure concerns, the patient exhibits mild peripheral edema, which is new since the last evaluation. This could suggest fluid retention, likely related to worsening kidney function and possibly influenced by dietary sodium intake or medication side effects. His weight has increased by 2 kilograms over the past two weeks, corroborating the fluid retention hypothesis. Additional bloodwork reveals mild metabolic acidosis, with a serum bicarbonate level of 19 mmol/L, necessitating a discussion on the potential need for bicarbonate supplementation to address the acid-base imbalance.

Considering these developments, the healthcare team must re-evaluate the patient's medication regimen, particularly focusing on diuretics' role in managing fluid overload and potential adjustments to antihypertensive therapy to prevent orthostatic complications. A dietary consultation may also be beneficial to reinforce low-sodium dietary practices and address any nutritional deficiencies. By addressing these moderate complications, the team aims to prevent further progression of CKD and enhance the patient's quality of life, while also preparing for the potential need for more advanced interventions if the patient's condition continues to deteriorate.

Section 3

Following the implementation of adjustments in the patient's treatment plan, the healthcare team focuses on the response to interventions. The patient is placed on a modified antihypertensive regimen, reducing the dosage of the current medications to alleviate episodes of orthostatic hypotension. In tandem, a loop diuretic is introduced with cautious titration to manage the mild peripheral edema and fluid overload. Over the next week, the patient undergoes close monitoring, with particular attention to his blood pressure, weight, and fluid status.

During follow-up assessments, the patient's blood pressure stabilizes at an average of 110/70 mmHg, indicating an improvement in hemodynamic stability without inducing orthostatic symptoms. The episodes of dizziness have diminished significantly, and the patient's energy levels show a slight improvement, although fatigue persists to some degree. The weight has decreased by 1 kilogram, suggesting a positive response to the diuretic therapy and reduction in fluid retention. However, a repeat laboratory evaluation reveals that the metabolic acidosis persists, with serum bicarbonate remaining at 19 mmol/L, warranting further consideration for bicarbonate supplementation.

Despite these positive changes, the patient reports new-onset muscle cramps, particularly in the lower extremities, which may be attributed to the diuretic's effects on electrolyte balance. An analysis of serum electrolytes reveals a mild hypokalemia, with a potassium level of 3.2 mmol/L, necessitating electrolyte management to prevent further complications. This new development requires the healthcare team to reassess the patient's electrolyte supplementation and dietary intake while continuing to monitor kidney function and overall health. These clinical insights will guide the next steps in optimizing the patient's management plan, aiming to maintain stability and enhance quality of life in the face of chronic kidney disease.

Section 4

As the healthcare team continues to monitor the patient, they note a gradual improvement in some areas while new complications arise. During a routine follow-up visit, the patient reports experiencing persistent muscle cramps along with a new complaint of tingling sensations in his fingers and toes. A focused physical examination reveals mild peripheral neuropathy, characterized by reduced sensation in the extremities. The patient's blood pressure remains stable at 112/72 mmHg, and his heart rate is regular at 78 beats per minute. However, the persistence of muscle cramps prompts further investigation into the underlying causes.

A comprehensive panel of laboratory tests is conducted, revealing that the patient's serum potassium level has further decreased to 2.9 mmol/L, indicating worsening hypokalemia. Additionally, the serum calcium level is noted to be at the lower end of normal, while magnesium levels are slightly below normal range at 1.4 mg/dL. These findings suggest that the diuretic therapy, while effective in managing fluid overload, has contributed to increased electrolyte imbalances. The metabolic acidosis remains unchanged, with a bicarbonate level steady at 18 mmol/L. The healthcare team recognizes the need for immediate intervention to address the electrolyte disturbances, as these imbalances could exacerbate the patient's chronic kidney disease and lead to further complications.

In response to these diagnostic results, the team revises the patient's treatment plan to include oral potassium and magnesium supplements. Dietary counseling is provided to enhance intake of potassium-rich foods, while monitoring continues for signs of improvement or deterioration in muscle function and sensation. The potential for calcium supplementation is also considered, keeping in mind the need to maintain a delicate balance due to the patient's kidney condition. As the patient embarks on this adjusted regimen, the healthcare team emphasizes the importance of regular follow-ups and laboratory assessments to ensure effective management and to prevent further complications. The goal remains to optimize the patient's electrolyte balance, improve his symptoms, and maintain stability in his ongoing battle with chronic kidney disease.

Section 5

As the healthcare team continues to closely monitor the patient's response to the revised treatment plan, they observe some initial improvements in his symptoms. The patient reports a slight reduction in the frequency of muscle cramps and a decrease in the tingling sensations in his fingers and toes. During a follow-up visit, his physical examination reveals a mild improvement in peripheral sensation, suggesting a positive response to the electrolyte supplementation. However, the team remains vigilant, aware that chronic kidney disease can lead to unpredictable changes in the patient's condition.

Yet, as days progress, the patient begins to experience fatigue and weakness that seem disproportionate to his level of physical activity. Concerned, the healthcare team orders a new set of laboratory tests to investigate these symptoms further. The results show a small but significant increase in the patient's serum creatinine level, now at 2.1 mg/dL, compared to previous readings. This indicates a potential worsening of renal function. Concurrently, his serum potassium has improved to 3.4 mmol/L, but his magnesium level remains slightly below normal at 1.6 mg/dL. The slight decline in renal function is a notable finding, prompting the team to consider potential causes such as the cumulative effects of medication or dietary factors, or perhaps a new underlying issue.

In light of these developments, the healthcare team decides to adjust the treatment plan once more. They reduce the dosage of diuretics to minimize renal strain while maintaining electrolyte supplementation. An emphasis is placed on optimizing the patient's diet to support kidney health and address the persistent low magnesium levels. The team also initiates a more frequent monitoring schedule to detect any further changes in renal function or electrolyte balance. By maintaining a proactive approach, they aim to stabilize the patient's condition and prevent further deterioration, understanding that ongoing assessment and timely intervention are crucial in managing chronic kidney disease.